Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

This episode is in Italian. For the English version, please
see the main feed.


Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare
l’efficacia e la sicurezza di un regime di farmaci per curare la
tubercolosi in individui con tubercolosi pre-estesa
farmaco-resistente.


Leggi l'articolo completo:


https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres


Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv